第 1 到 4 筆結果,共 4 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis | Tseng, Chi-Yang; Fu, Yu-Hsuan; DA-LIANG OU ; Lu, Jeng-Wei; HSIN-AN HOU ; LIANG-IN LIN | Cancer gene therapy | 0 | 0 | |
2 | 2022 | Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias | Su, Kuan-Wei; DA-LIANG OU ; Fu, Yu-Hsuan; HWEI-FANG TIEN ; HSIN-AN HOU ; LIANG-IN LIN | Cancer Gene Therapy | 3 | 2 | |
3 | 2016 | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | Lu J.-W; Wang A.-N; Liao H.-A; Chen, Chien-Yuan ; HSIN-AN HOU ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Cancer Letters | 25 | 26 | |
4 | 2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; HSIN-AN HOU ; WEN-CHIEN CHOU ; DA-LIANG OU ; SUNG-LIANG YU ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia | 39 | 37 |